Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
63,329,967
-
Share change
-
+1,742,635
-
Total reported value
-
$1,276,718,425
-
Put/Call ratio
-
29%
-
Price per share
-
$20.16
-
Number of holders
-
169
-
Value change
-
-$57,244,649
-
Number of buys
-
87
-
Number of sells
-
115
Institutional Holders of DICERNA PHARMACEUTICALS INC - COM (DRNA) as of Q3 2021
As of 30 Sep 2021,
DICERNA PHARMACEUTICALS INC - COM (DRNA) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,329,967 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, Bain Capital Life Sciences Investors, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Aquilo Capital Management, LLC, MORGAN STANLEY, JPMORGAN CHASE & CO, and Woodline Partners LP.
This page lists
169
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.